Verified Nov 2026
Other
·
Neuilly-sur-Seine, Ile-de-France
·
Since
Opella is a France-headquartered consumer healthcare company based in Neuilly-sur-Seine, with an estimated workforce of 10,000 to 50,000 and an estimated revenue band of $1 to 5 billion. It produces over-the-counter medicines, vitamin and mineral supplements, and medical devices for consumer self-care, serving customers across more than 100 countries. In April 2026 it announced a partnership with Lovell to broaden access to OTC healthcare products for the U.S. Department of Veterans Affairs and Department of Defense.
Opella at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Headquarters
Neuilly-sur-Seine, Ile-de-France
Certifications
ISO 9001
Import activity
190
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Consumer Goods
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
190
Named foreign suppliers
26
Top origins
China · Mexico · South Korea · United Kingdom
Shared foreign counterparties do not establish that these companies buy from Opella.
What this tells a buyer
Opella announced a major production investment in Mexico for its Enterogermina digestive health product in July 2026, as reported on its own website.
The company holds ISO 9001 certification and is a certified B Corporation, and its catalogue includes OTC brands such as Doliprane and Allegra alongside dietary supplements such as Essentiale.
Opella operates an estimated 13 manufacturing sites and 4 science and innovation centers, and in October 2026 it launched a five-year partnership with the World Allergy Organization on allergy care.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Opella is a France-headquartered consumer healthcare company based in Neuilly-sur-Seine, with an estimated workforce of 10,000 to 50,000 and an estimated revenue band of $1 to 5 billion. It produces over-the-counter medicines, vitamin and mineral supplements, and medical devices for consumer self-care, serving customers across more than 100 countries. In April 2026 it announced a partnership with Lovell to broaden access to OTC healthcare products for the U.S. Department of Veterans Affairs and Department of Defense.
At a glance
Attribute | Detail |
|---|---|
Headquarters | Neuilly-sur-Seine, Ile-de-France |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
Certifications | ISO 9001 |
What Opella makes
The company holds ISO 9001 certification and is a certified B Corporation, and its catalogue includes OTC brands such as Doliprane and Allegra alongside dietary supplements such as Essentiale.
Products and capabilities described on the company's own site include Emissions, Pump (source: opella.com).
Certifications
Opella is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — opella.com
Trade and customs footprint
Opella announced a major production investment in Mexico for its Enterogermina digestive health product in July 2026, as reported on its own website. US customs bill-of-lading records list 190 inbound shipments across 26 foreign suppliers, with top origins including China · Mexico · South Korea · United Kingdom.
Latest developments
2026-10-16 — Press Release. Opella and World Allergy Organization launch five-year partnership to improve allergy care for millions worldwide. (opella.com)
2026-07-22 — Press Release. Opella expands global supply network for digestive health with major Enterogermina production investment in Mexico. (opella.com)
2026-04-29 — Opella and Lovell Announce Partnership to Increase Access to OTC Healthcare Products for VA, DoD (einpresswire.com)
2026-04-17 — Communiqué de presse. Opella célèbre 60 ans d’histoire à Compiègne. (opella.com)
2026-04-15 — Navan Selected by Opella to Streamline Global Travel and Expense (businesswire.com)
2026-03-20 — Press Release. Opella Healthcare launches breakthrough electrification project with the backing of $1.94M in Australian federal funds. (opella.com)
Facilities
Opella is headquartered in Neuilly-sur-Seine, Ile-de-France. Public sources also reference these locations:
Origgio, Italy — opella.com
Company details
Opella operates an estimated 13 manufacturing sites and 4 science and innovation centers, and in October 2026 it launched a five-year partnership with the World Allergy Organization on allergy care. Opella has an estimated 10,000-50,000 employees, and is headquartered in Neuilly-sur-Seine, Ile-de-France.
Frequently asked questions
What does Opella do?
Opella is a France-headquartered consumer healthcare company based in Neuilly-sur-Seine, with an estimated workforce of 10,000 to 50,000 and an estimated revenue band of $1 to 5 billion. It produces over-the-counter medicines, vitamin and mineral supplements, and medical devices for consumer self-care, serving customers across more than 100 countries. In April 2026 it announced a partnership with Lovell to broaden access to OTC healthcare products for the U.S. Department of Veterans Affairs and Department of Defense.
Where is Opella headquartered?
Opella is headquartered in Neuilly-sur-Seine, Ile-de-France (157 Avenue Charles de Gaulle, Neuilly-sur-Seine, Ile-de-France, 92200).
How big is Opella?
Opella has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Opella hold?
Opella lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Opella import from overseas suppliers?
US customs bill-of-lading records show 190 inbound shipments for Opella, with top origins including China · Mexico · South Korea · United Kingdom.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.